Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

1(33.3%)

Phase 2

1(33.3%)

Phase 3

1(33.3%)

3Total

N/A(1)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07556835Not Yet Recruiting

Outcomes After Liver and Biliary Resection at a High-Volume Center

Role: lead

NCT07496242Recruiting

Immunological Phenotype of Desmoid-fibromatosis-affected Patients.

Role: collaborator

NCT06863896Not Yet Recruiting

Laparoscopic Hartmann's Reversal Procedure: In the Absence of Standardized Guidelines, we Started a Database of Patient Submitted Reversal Hartman With Standard Technique and Laparoscopic Technique, Prospectively for One Year and a Follow-up Period of 6 Months

Role: lead

NCT06044623Phase 3Recruiting

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

Role: collaborator

NCT06391411Not ApplicableCompleted

Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Degeneration - The Gut-Retina-axis Study

Role: collaborator

NCT05250596Phase 2Completed

COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)

Role: lead

NCT04141410Unknown

Global Longitudinal Strain Assessment in Cardiogenic Shock During Sepsis

Role: lead

All 7 trials loaded